Packaging that
shows when it's
been compromised.
A patented, validated oxygen-reactive ink technology that visibly signals tampering, puncture, and seal failure — engineered to integrate onto existing packaging lines with minimal process disruption.
This portfolio is patented, validated, and scalable — available now for strategic acquisition or exclusive licensing.
The Color Change Speaks for Itself
Our scientist updated the formula to full FD&C standards in 2026. The indicator visibly changes color within 1 minute, 10 seconds of packaging breach — no scanner, no app, no infrastructure required.
Simple to Deploy.
Impossible to Miss.
The commercial value is straightforward: any packaging that can be compromised can now tell you when it has been — visibly, immediately, and without additional infrastructure. Here is how the technology delivers that.
Apply
The oxygen-reactive ink is applied as an outer coating layer onto existing packaging — flexible films, rigid containers, blister packs, cartons — using standard coating or printing equipment. No changes to the underlying packaging design or manufacturing workflow are required.
Breach
When packaging integrity is compromised — by tampering, puncture, pressure, seal failure, or environmental oxygen exposure — the ink layer is activated. The reaction begins immediately upon contact with oxygen.
Indicate
The ink visibly changes color — producing a clear, human-visible signal that the package has been compromised. No scanner, reader, or app required. The signal is legible to distributors, retailers, pharmacists, and end consumers alike.
Adjustable Response Time
Formulation is calibrated for the specific application — from near-immediate response (minutes) to extended windows (days or weeks) — enabling precise fit for pharmaceutical, perishable food, or logistics use cases.
Minimal Process Disruption
Engineered to integrate onto existing packaging lines as an outer coating layer. Designed to minimize changes to packaging design, filling lines, and manufacturing equipment across standard substrates.
Multi-Substrate Compatible
Applicable to flexible films, rigid plastics, glass, aluminum, paper-based, and composite packaging materials across industries.
FD&C Standards Compliant
Formula updated in 2026 to full FD&C standards. Current bloom time: 1 minute, 10 seconds. Complements existing track-and-trace and serialization systems.
Built for the Industries
Where Integrity Matters Most
The technology's adjustable formulation and substrate versatility make it applicable across every major packaging vertical where tampering, counterfeiting, or spoilage represent material risk.
Pharmaceutical
Tamper-evident blister packs, drug delivery devices, vials, and clinical trial supply chains. Supports DSCSA compliance and anti-counterfeiting mandates.
High PriorityFood & Beverage
Cold-chain breach detection for perishables, freshness indication for retail, spoilage liability reduction for distributors and food manufacturers.
High PriorityLogistics & E-Commerce
In-transit damage confirmation for high-value goods, insurance claim evidence, last-mile integrity assurance for direct-to-consumer fulfillment.
Growth VerticalConsumer Products
OTC drug tamper evidence, infant formula integrity, personal care anti-counterfeiting, and retail theft deterrence for premium consumer brands.
Growth VerticalWhich Partner Are You?
The 3BP patent portfolio creates strategic value across multiple industries. Select your sector to understand the specific opportunity.
Pharma & Medical
Tamper-evident drug packaging, DSCSA compliance support, clinical trial chain-of-custody, and anti-counterfeiting for high-value therapeutics.
Explore This Fit →Food & Perishables
Cold-chain breach detection, spoilage liability reduction, consumer-facing freshness signals, and retail shrink reduction for food manufacturers and distributors.
Explore This Fit →Packaging Manufacturers
Acquire or license the core IP to differentiate your product portfolio, capture premium market segments, and deliver verified integrity to your customers.
Explore This Fit →Logistics & Security
In-transit damage verification, high-value goods protection, insurance claim evidence, and last-mile integrity assurance for logistics and e-commerce operators.
Explore This Fit →A Defensible Patent Portfolio
Protected Through 2034
3BP holds six active patent records across the United States, Europe (including Spain and Poland), and Canada — covering both the core damage-indicating chemistry and a track-and-trace serialization system. All patents are assigned to 3BP, Inc. and maintained in good standing.
Full patent documentation, specifications, and prosecution history are available under NDA to qualified strategic partners and acquirers.
Request NDA & Documentation| Patent Number | Title / Coverage | Jurisdiction | Status | Expiry |
|---|---|---|---|---|
| EP 2994080 | Damage-Indicating Flexible Packaging — oxygen-reactive breach detection for sealed consumer & pharmaceutical packaging | Europe (EPC) | Validated | May 2034 |
| EP 2994080 (ES) | Damage-Indicating Flexible Packaging — validated and enforceable in Spanish market | Spain | Granted | May 2034 |
| EP 2994080 (PL) | Damage-Indicating Flexible Packaging — validated and enforceable in Polish market | Poland | Granted | May 2034 |
| US 10,029,841 B2 | Damage-Indicating Packaging — core US patent covering oxygen-reactive indicator layer on existing packaging substrates | United States | Granted | May 2034 |
| US 11,542,080 | Track and Trace Packaging and Systems — serialization, chain-of-custody verification & supply chain integrity | United States | Granted | May 2034 |
| CA 3,107,428 | Track and Trace Packaging and Systems — Canadian coverage for serialization & traceability applications | Canada | Published | Active |
All patents assigned to 3BP, Inc. Full specifications available under executed NDA. Report prepared by Leech Tishman, March 2026.
Why the Window Is Open Now
Regulatory Tailwinds
FDA, DSCSA, EU MDR, and global serialization mandates are increasing pressure on pharmaceutical and medical device manufacturers to implement verifiable packaging integrity — creating immediate, compliance-driven demand.
Supply Chain Risk at Peak
Post-COVID disruption, port vulnerabilities, and geopolitical instability have elevated the business case for tamper-detection and damage-indication across every major vertical. The risk is no longer theoretical.
Smart Packaging Acceleration
The global smart packaging market is projected to exceed $45B by 2030 at 8%+ CAGR. Active and intelligent indicators are among the fastest-growing sub-segments — and 3BP's patents cover the core mechanism.
Portfolio Fully Maintained
All 6 patents are active and in good standing through 2034. The portfolio is complete, defensible, and ready for immediate acquisition or licensing — with no pending litigation or encumbrances.
Prototype Demonstrated
Working prototypes have been produced with 3BP branding and demonstrated to strategic advisors. Physical samples are available for qualified partners proceeding to due diligence.
No Exclusive Commitment
3BP has not entered any exclusive arrangement. The first-mover advantage remains available to a single strategic partner willing to move decisively on acquisition or exclusive licensing.
The Founding Team
3BP was founded by a multidisciplinary team with backgrounds spanning packaging science, business development, and strategic operations.
Veonous & Auguste Jaques
Co-Founders & OperationsCo-founders responsible for day-to-day operational continuity, patent maintenance, and scientific development. Auguste serves as the primary liaison to the company's scientific team.
L. Kris Gaines
Co-Founder, Named Inventor & Board MemberOriginated the Damage-Indicating Packaging™ concept and has driven the current commercialization push. Named inventor on the core patents with a founding equity position in 3BP, Inc.
Acquisition or Exclusive License --
We Are Ready to Move
3BP is currently engaged with M&A advisors and in active discussions with strategic partners. We are evaluating two primary structures for the right partner.
Full IP Acquisition
3BP transfers ownership of the complete patent portfolio — all 6 active patents through 2034 — to the acquiring party for a negotiated lump-sum consideration.
Exclusive License
3BP grants an exclusive, field-of-use or territory-based license to a single strategic partner, retaining IP ownership while providing full market exclusivity within the agreed scope.
Ready to Move Forward?
We are currently engaged with M&A advisors and evaluating acquisition and exclusive licensing structures. Reach out directly to request our patent portfolio brief, prototype documentation, or NDA paperwork.